[ Back to EurekAlert! ]

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute

Levi Garraway, Dana-Farber Cancer Institute

Caption: Levi Garraway, M.D., Ph.D., Dana-Farber Cancer Institute, Broad Institute, and his colleagues have identified two new mutations that collectively occur in 71 percent of malignant melanoma tumors. These highly "recurrent" mutations may be the most common mutations in melanoma cells found to date and are the first to be discovered in the vast regions of DNA in cancer cells that do not contain genetic instructions for making proteins.

Credit: Sam Ogden

Usage Restrictions: None

Related news release: Researchers discover new mutations driving malignant melanoma


[ Back to EurekAlert! ]